LIFESTREAM TECHNOLOGIES INC
NT 10-Q, 2000-05-16
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: MONET ENTERTAINMENT GROUP LTD, NT 10-K, 2000-05-16
Next: NATIONWIDE FINANCIAL SERVICES INC/, 8-K, 2000-05-16



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   Form 12b-25

                           NOTIFICATION OF LATE FILING

(Check            One) [ ] Form 10-K and Form 10-KSB [ ] Form 20-F [ ] Form 11-K
                  [x] Form 10-Q and Form 10-QSB [ ]Form N-SAR

                  For Period Ended: March 31, 2000
                  [ ] Transition Report on Form 10-K
                  [ ] Transition Report on Form 11-K
                  [ ] Transition Report on Form 10-Q
                  [ ] Transition Report on Form N-SAR
                  For the Transition Period Ended:

Read Attached Instruction Before Preparing Form. Please Print or Type. Nothing
in this form shall be construed to imply that the Commission has verified any
information contained herein.

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

Full Name of Registrant                       Lifestream Technologies, Inc.

Former Name if Applicable                     N/A

Address of principal Executive Office
(Street and Number)                           510 Clearwater Loop, Suite 101

City, State and Zip Code                      Post Falls, ID 83854

PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25b, the following should
be completed. (Check box if appropriate)

[x]           (a) The reasons described in reasonable detail in Part III of this
              form could not be eliminated without unreasonable effort or
              expenses:
[x]           (b) The subject annual report, semi-annual report on Form 10-K,
              Form 20-F, 11-F, Form N-SAR, or portion thereof, will be filed on
              or before the fifteenth calendar day following the prescribed due
              date; or the subject quarterly report or transition report on Form
              10-Q, or portion thereof will be filed on or before the fifth
              calendar day following the prescribed due date; and
[ ]           (c) The accountant's statement or other exhibit required by Rule
              12b-25(c) has been attached if applicable.

<PAGE>

PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period. (Attached Extra Sheets if needed) Lifestream
Technologies, Inc. is unable to file its quarterly report on Form 10-QSB by the
prescribed due date because management has been unable to obtain certain key
documentation and information without unreasonable effort and expense,
specifically due to (a) the execution of several material subsequent agreements
for which proper documentation has not yet become available.

(1)    Name and telephone number of person to contact in regard to this
       notification

       Brett Sweezy                    208                457-9409
       ------------                    ---                --------
         (Name)                    (Area Code)       (Telephone Number)

(2)    Have all other periodic reports required under Section 13 or 15(d) of the
       Securities Exchange Act of 1934 or Section 30 of the investment Company
       Act of 1940 during the preceding 12 months (or for such shorter period
       that the registrant was required to file such reports) been filed? If
       answer is no, identify report(s).

                           [x]  Yes     [ ]  No

(3)    Is it anticipated that any significant change in results of operation
       from the corresponding period for the last fiscal year will be reflected
       by the earnings statements to be included in the subject report or
       portion thereof?

                           [ ]  Yes     [x]  No

       If so, attach an explanation of the anticipated change, both narratively
       and quantitatively, and if appropriate, state the reasons why a
       reasonable estimate of the results cannot be made.

Lifestream Technologies, Inc.
- -----------------------------
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.


Date May 15, 2000                   By      /s/ Brett Sweezy, CFO
     ------------                           ---------------------

                                       2


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission